Assessment of GABA-B, metabotropic glutamate, and opioid receptor involvement in an animal model of binge drinking.
Drinking to intoxication or binge drinking is a hallmark characteristic of alcohol abuse. Although hard to model in rodents, the scheduled high alcohol consumption (SHAC) procedure generates high, stable ethanol intake and blood ethanol concentrations in mice to levels consistent with definitions of binge drinking. The purpose of the present studies was to determine the effects of pharmacological manipulation of the opioidergic, glutamatergic, and γ-aminobutyric acid (GABA)ergic systems on binge drinking with the SHAC procedure. Parallel manipulations were conducted in mice trained in operant self-administration of either sucrose or ethanol. For the SHAC procedure, genetically heterogeneous Withdrawal Seizure Control mice were given varying periods of fluid access, with a 30-min ethanol session every third day (total of seven). Mice were pretreated intraperitoneally with naltrexone (0, 0.6, or 1.25 mg/kg), baclofen (0, 2.5, or 5.0 mg/kg), or 2-methyl-6-(phenylethynyl)-pyridine (MPEP; 0, 3.0, or 10.0 mg/kg) before each ethanol session. For the operant self-administration procedure, separate groups of C57BL/6 mice were trained to complete a single response requirement (16 presses on the active lever) to gain 30 min of access to an ethanol or a sucrose solution. Mice received pretreatments of the same doses of naltrexone, MPEP, or baclofen before the self-administration sessions, with saline injections on intervening days. Naltrexone produced a dose-dependent decrease in binge drinking, and the highest dose also significantly decreased operant self-administration of ethanol and sucrose. Both doses of baclofen significantly decreased binge alcohol consumption, but the higher dose also tended to decrease water intake. The highest dose of baclofen also significantly decreased operant self-administration of sucrose. MPEP (10 mg/kg) significantly decreased binge alcohol consumption and sucrose self-administration. These results indicate that manipulation of the opioidergic, glutamatergic, and GABAergic systems significantly decreased binge drinking.
Tanchuck
Michelle A
MA
Department of Behavioral Neuroscience, Oregon Health & Science University, Portland, OR 97239, USA. tanchuck@ohsu.edu
Yoneyama
Naomi
N
Ford
Matthew M
MM
Fretwell
Andrea M
AM
Finn
Deborah A
DA
D000428:Alcohol Drinking / Q000188:drug therapy; D000818:Animals; D001418:Baclofen / Q000494:pharmacology; D004195:Disease Models, Animal; D000431:Ethanol / Q000008:administration & dosage / Q000097:blood / Q000506:poisoning*; D018691:Excitatory Amino Acid Antagonists / Q000494:pharmacology; D058786:GABA-B Receptor Agonists / Q000494:pharmacology; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D009271:Naltrexone / Q000494:pharmacology; D009292:Narcotic Antagonists / Q000494:pharmacology; D011725:Pyridines / Q000494:pharmacology; D018080:Receptors, GABA-B / Q000502:physiology*; D018094:Receptors, Metabotropic Glutamate / Q000502:physiology*; D011957:Receptors, Opioid / Q000502:physiology*; D012646:Self Administration; D013395:Sucrose / Q000008:administration & dosage
D018691:Excitatory Amino Acid Antagonists; D058786:GABA-B Receptor Agonists; D009292:Narcotic Antagonists; D011725:Pyridines; D018080:Receptors, GABA-B; D018094:Receptors, Metabotropic Glutamate; D011957:Receptors, Opioid; D000431:Ethanol; D013395:Sucrose; D009271:Naltrexone; C121465:6-methyl-2-(phenylethynyl)pyridine; D001418:Baclofen